Amitriptyline: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) m (→Overview) |
||
| Line 9: | Line 9: | ||
==Overview== | ==Overview== | ||
'''Amitriptyline''' ('''Elavil''', '''Endep''', '''Levate''' and [[Amitriptyline#Brand_names|many others]]) is a [[tricyclic antidepressant]] (TCA). It is the most widely used TCA and is an efficacious treatment for [[major depressive disorder]] (clinical depression). It was originally developed by [[Merck & Co.|Merck]] and was initially approved by the [[United States]] [[Food and Drug Administration]] (FDA) on 7 April 1961.<ref name="pmid18204333">{{cite journal | author = Fangmann P, Assion HJ, Juckel G, González CA, López-Muñoz F | title = Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics | journal = Journal of Clinical Psychopharmacology |volume = 28 | issue = 1 | pages = 1–4 |date=February 2008 | pmid = 18204333 | doi = 10.1097/jcp.0b013e3181627b60 | url =http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0271-0749&volume=28&issue=1&spage=1}}</ref> | |||
==Category== | ==Category== | ||
Revision as of 01:35, 10 February 2014
| Amitriptyline |
|---|
| AMITRIPTYLINE HYDROCHLORIDE® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Amitriptyline |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
For patient information about Amitriptyline, click here.
Synonyms / Brand Names: Amitriptyline Hydrochloride, Amitriptyline HCL, Amitriprolidine, Amitriptylin, Amitryptiline, Amitryptyline, Amytriptiline, Adepress, Adepril, Amitid, Amitril, Damilan, Damilen, dAmitriptyline, Elanil, Elavil, Endep, Flavyl, Hexathane, Horizon, Lantron, Laroxil, Laroxyl, Lentizol, Proheptadiene, Redomex, Saroten, Sarotex, Seroten, Sylvemid, Triptanol, Triptilin, Triptisol, Tryptanol, Tryptizol
Overview
Amitriptyline (Elavil, Endep, Levate and many others) is a tricyclic antidepressant (TCA). It is the most widely used TCA and is an efficacious treatment for major depressive disorder (clinical depression). It was originally developed by Merck and was initially approved by the United States Food and Drug Administration (FDA) on 7 April 1961.[1]
Category
Antidepressants
FDA Package Insert
AMITRIPTYLINE HYDROCHLORIDE tablet, film coated
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
References
- ↑ Fangmann P, Assion HJ, Juckel G, González CA, López-Muñoz F (February 2008). "Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics". Journal of Clinical Psychopharmacology. 28 (1): 1–4. doi:10.1097/jcp.0b013e3181627b60. PMID 18204333.